Siemens Reports Record Fiscal 2026 Results, Raises Mid-Term Targets
For fiscal 2025/26, comparable growth was 8% and industrial business profit reached a record €13.3 billion, up from €11.8 billion. EPS before PPA effects was €11.76, above raised guidance of €11.20–€11.50. Siemens raised its mid-term growth corridor to 7%–11%, proposed a €5.50 dividend and plans to transfer a 34.1% stake in Siemens Healthineers to shareholders next year.
For the 2025/26 fiscal year, Siemens reported an 8% comparable growth rate and a record industrial business profit of 13.3 billion euros, up from 11.8 billion euros in the previous year. The company's digital business revenue grew by 16% to 10.9 billion euros, driven by demand for electrification, digitalization, and industrial AI. Earnings per share before PPA effects reached 11.76 euros, exceeding the company's raised guidance range of 11.20 to 11.50 euros. Consequently, Siemens raised its mid-term growth corridor to 7%—11% and proposed a dividend of 5.50 euros per share.
Additionally, the company announced plans to transfer a 34.1% stake in its medical technology subsidiary, Siemens Healthineers, to shareholders in the coming year.